Accepted_test
Currently, most bacteria are resistant to the main groups of antibiotics, and therefore the search for modern antibacterial agents remains relevant. The new innovative peptidomimetic SAMP-1 is of interest due to the absence of a specific microbial target, which pushes back the possibility of resistance to it in microorganisms. This work presents a microbiological study of antibacterial and antifungal properties of SAMP-1 on validation test strains and determination of its minimum inhibitory concentration. The acute toxicity study was performed on CD-1 line mice under conventional and SPF vivarium conditions. The presence of SPF status did not influence the results of the study. A safe dose range not causing lethal outcome at a single intravenous injection was determined. A semi-lethal dose was found, as well as LD10 and LD90.